Concepedia

Publication | Open Access

A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure

DOIFull Paper Access

118

Citations

11

References

2013

Year

Piotr Ponikowski, Veselin Mitrović, Mikhail Ruda, Alberto Fernández, Adriaan A. Voors, A. A. Vishnevsky, Gad Cotter, Olga Milo, Ute Laessing, Yiming Zhang,
European Heart Journal

Abstract

The haemodynamic effects of serelaxin observed in the present study provide plausible mechanistic support for improvement in signs and symptoms of congestion observed with this agent in AHF patients. ClinicalTrials.gov identifier NCT01543854.

References

YearCitations

Page 1